This information is intended for UK healthcare professionals only.
This video has been commissioned and developed by Pfizer.
Throughout the world, 1 in 5 people suffer from moderate to severe chronic pain.1–4
Chronic pain can have a significant negative impact on those afflicted, with effects including sleeplessness, decreased activity, and mood changes such as depression.5
This video details the different pathophysiologies of acute and chronic pain.
- Breivik H, Collet B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain. 2006;10:287-333.
- Schopflocher D, Taenzer P, Jovey R The prevalence of chronic pain in Canada. Pain Res Manag. 2011;16:445-450.
- Johannes CB, Le TK, Zhou X, Johnston JA, Dworkin RH. The prevalence of chronic pain in United States adults: results of an Internet-based survey. J Pain. 2010;11:1230-1239.
- Bouhassira D, Lantéri-Minet M, Attal N, Laurent B, Touboul C. Prevalence of chronic pain with neuropathic characteristics in the general population. Pain. 2008;136:380-387.
- OARSI. Osteoarthritis: A Serious Disease, Submitted to the U.S. Food and Drug Administration. December 1, 2016
Date of preparation: May 2021